Screener
4D Molecular Therapeutics FDMT Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from 4D Molecular Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211939
FAQ
- What is 4D Molecular Therapeutics's book value per share?
- 4D Molecular Therapeutics (FDMT) reported book value per share of $6.64 in Q1 2026.
- How has 4D Molecular Therapeutics's book value per share changed year-over-year?
- 4D Molecular Therapeutics's book value per share decreased by 21.2% year-over-year, from $8.43 to $6.64.
- What is the long-term trend for 4D Molecular Therapeutics's book value per share?
- Over 5 years (2020 to 2025), 4D Molecular Therapeutics's book value per share has grown at a -26.2% compound annual growth rate (CAGR), from $39.87 to $8.73.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about 4D Molecular Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude